Tracy L. Deegan
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Cytokine Signaling Pathways and Interactions, Innovative Microfluidic and Catalytic Techniques Innovation, Myeloproliferative Neoplasms: Diagnosis and Treatment, Computational Drug Discovery Methods
Most-Cited Works
- → On the Development of New Poly(styrene-oxyethylene) Graft Copolymer Resin Supports for Solid-Phase Organic Synthesis(1998)80 cited
- → Parallel synthesis of 1,2,4-oxadiazoles using CDI activation(1999)79 cited
- → Non-acidic cleavage of Wang-derived ethers from solid support: Utilization of a mixed-bed scavenger for DDQ(1997)60 cited
- → Discovery of (+)-N-(3-Aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide (AZD4877), a Kinesin Spindle Protein Inhibitor and Potential Anticancer Agent(2011)43 cited
- → Discovery of Potent KIFC1 Inhibitors Using a Method of Integrated High-Throughput Synthesis and Screening(2014)42 cited
- → Automated chemical synthesis: From resins to instruments(1997)27 cited
- → Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors(2018)26 cited
- → Identification of azabenzimidazoles as potent JAK1 selective inhibitors(2015)23 cited
- → Analysis of 9-fluorenylmethoxycarbonyl (FMOC) loading of solid-phase synthesis resins by gas chromatography(1998)22 cited
- → Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer(2008)19 cited